Live
FierceBiotechChina’s Oricell raises $110M for carcinoma CAR-T plans ahead of IPO pushFierceBiotech'Can it actually deliver?': Why Big Pharma is making the leap to the quantum realmEndpoints NewsNovo's double departures: As GLP-1 luminary retires, an obesity leader goes to Boehringer IngelheimBioPharma DiveWomen have awaited a revolution in menopause. It hasn’t arrived.Endpoints NewsChina-based CAR-T company Oricell raises $40M more as it looks to go publicIlluminaIllumina Stock: Competitive Threats Priced In (NASDAQ:ILMN) - Seeking AlphaRoche MediaCall for Applications: Roche Health Journalism Award 2026 - fundsforNGOsFierceBiotechChutes & Ladders—Former TreeFrog CEO leaps to Orano MedThermo FisherSeer, Thermo Fisher bring deep mass spec proteomics to 10,000-sample Singapore biobank study - R&D WorldThermo FisherThermo Fisher Partnership With PRECISE Puts Proteomics At Core Of TMO Story - simplywall.stFierceBiotechPhilips recalls Trilogy Evo ventilator software, warns of ‘under-delivery’ of therapyeLifeTranslational control in the spinal cord regulates gene expression and pain hypersensitivity in the chronic phase of neuropathic pain
FierceBiotech Apr 10, 2026

China’s Oricell raises $110M for carcinoma CAR-T plans ahead of IPO push

China’s Oricell raises $110M for carcinoma CAR-T plans ahead of IPO push

Original
Body unavailable. Use the original source.

Directory

59 All